Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

248.98
Delayed Data
As of Jul 22
 +1.14 / +0.46%
Today’s Change
195.50
Today|||52-Week Range
340.34
-20.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line-241.6M5.3B-629.3M256.4M
 
 
 
 
 
Depreciation1.7B1.2B1.6B1.6B
 
 
 
 
 
Total Other Cash Flow961.8M1.2B696.5M204.8M
 
 
 
 
 
Funds From Operations2.2B896.1M1.8B1.6B
 
 
 
 
 
Funds From/For Other Operating Expenses783.1M-152.1M219.2M357.7M
 
 
 
 
 
Net Cash Flow - Operating Activities1.4B1.0B1.6B1.2B
 
 
 
 
 
 
InvestingIncrease In Investments-6.0M-6.0M2.7M0.00
 
 
 
 
Decrease In Investments--0.00883.0M19.0M
 
 
 
Capital Expenditures-111.6M-102.5M-104.2M-84.9M
 
 
 
 
 
Fixed Asset Disposal6.6M52.1M6.5M12.1M
 
 
 
 
 
Net Assets From Acquisitions -463.7M-132.8M-2.3B0.00
 
 
 
 
Other Investing - Sources65.3M0.00--0.00
 
 
Net Cash Flow Investing-529.4M-251.8M-2.4B-53.8M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings72.8M0.00799.3M900.0M
 
 
 
 
Long Term Debt Reduction-1.4B-230.5M-807.5M-854.2M
 
 
 
 
 
Net Proceeds Stock Sale65.6M87.6M34.2M69.6M
 
 
 
 
 
Common Preferred Redeemed-36.9M-7.2M-9.8M-53.2M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-68.7M-69.7M-69.7M-69.6M
 
 
 
 
 
Other Sources - Financing200.0K17.7M22.1M34.6M
 
 
 
 
 
Other Uses - Financing67.4M46.3M91.8M32.3M
 
 
 
 
 
Net Cash Flow - Financing-1.5B-248.4M-123.2M-5.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.7M-2.0M-1.4M5.2M
 
 
 
 
 
 
Net Change In Cash-598.7M548.0M-966.5M1.2B